Picture of Sartorius Stedim Biotech SA logo

DIM — Sartorius Stedim Biotech SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Sartorius Stedim Biotech H1 Net Profit At EUR 154.1 Mln

July 22 (Reuters) - Sartorius Stedim Biotech SA STDM.PA:

HALF-YEAR RESULTS 2025 OF SARTORIUS STEDIM BIOTECH

H1 SALES REVENUE AT 1,490 MILLION EUROS, UP 9.4 PERCENT

H1 UNDERLYING EBITDA INCREASES 19.3 PERCENT TO 462 MILLION EUROS

MANAGEMENT CONFIRMS GUIDANCE FOR 2025

H1 NET PROFIT AT EUR 154.1 MILLION

Source text: ID:nEQ1qfm46a

Further company coverage: STDM.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Sartorius Stedim Biotech SA

See all news